Augmex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Augmex

Understanding Augmex

Augmex is a combination antibiotic used to treat a variety of bacterial infections. It belongs to a group of medicines known as penicillins. By combining two distinct active components, the medication is designed to address bacteria that may otherwise be resistant to single-agent penicillin treatments.

Composition and Mechanism

The effectiveness of Augmex relies on the synergistic action of its two primary ingredients:

  • Amoxicillin: A broad-spectrum antibiotic that works by interfering with the ability of bacteria to form protective cell walls, which are essential for their survival.
  • Clavulanic Acid: A beta-lactamase inhibitor. While it does not kill bacteria directly, it prevents certain bacteria from producing enzymes that would normally break down and deactivate the amoxicillin.

By protecting the amoxicillin from enzymatic destruction, the clavulanic acid allows the antibiotic to remain effective against a wider range of bacterial strains.

Common Uses

Augmex is utilized for the treatment of infections caused by susceptible bacteria in different parts of the body. These typically include:

  • Respiratory Tract Infections: Such as pneumonia, bronchitis, and sinusitis.
  • Ear and Throat Infections: Including otitis media and tonsillitis.
  • Urinary Tract Infections: Affecting the bladder or kidneys.
  • Skin and Soft Tissue Infections: Including infections resulting from animal bites or dental abscesses.

This medication is only effective against bacterial infections and will not work for viral infections such as the common cold or the flu.

What side effects are possible with Augmex?

Possible Side Effects and Safety Information

Regulatory documents classify the possible effects of Augmex (Co-Amoxiclav) across several frequency categories and physiological systems. The most frequently documented adverse reactions, officially classified as Very Common or Common, primarily involve the gastrointestinal system and skin, including diarrhea, nausea, vomiting, and the appearance of a skin rash. Other effects documented at lower frequencies include dizziness, headache, and reversible changes in liver enzymes (AST/ALT).

Serious adverse reactions, though rare, are explicitly listed in official labeling. These include severe hypersensitivity reactions such as anaphylaxis and angioedema, as well as severe cutaneous adverse reactions (SCARs). The medicine is also associated with the potential for hepatobiliary disorders, including cholestatic jaundice and hepatitis, which may have a delayed onset, sometimes appearing weeks after treatment has stopped.

Specific safety considerations are defined for certain patient groups. Individuals with a history of penicillin allergy or prior hepatic dysfunction associated with Co-Amoxiclav are generally contraindicated. Furthermore, official regulatory information specifies that patients with moderate to severe renal or hepatic impairment require close monitoring or dose adjustment, reflecting specific safety constraints necessary for the appropriate use of the medicine.

Overdose and Emergency Response

Augmex Overdose and When to Seek Help

Taking more Augmex (amoxicillin/clavulanate) than prescribed can lead to an overdose. While serious outcomes are rare, an overdose requires immediate medical attention. The most common signs are related to the gastrointestinal system, though potential effects on the kidneys and nervous system should also be monitored.

Symptoms of Augmex Overdose

Overdose symptoms may include:

  • Severe nausea and vomiting
  • Diarrhea and stomach pain
  • Decreased frequency of urination or cloudy urine
  • Drowsiness or hyperactivity (especially in children)
  • Skin rash
  • Seizures (rare)

When to Seek Emergency Help

If you suspect an overdose, contact emergency medical services or a poison control center immediately. Treatment for an Augmex overdose is supportive, often focusing on managing symptoms and ensuring adequate hydration. Hemodialysis can be used to remove the drug from the bloodstream in severe cases, especially for patients with impaired kidney function.

Always store Augmex securely out of the reach of children to prevent accidental overdose. If a dose is missed, take it as soon as you remember, unless it is almost time for your next scheduled dose. Do not take two doses to make up for a missed one.

Therapeutic Uses of Augmex

What Augmex Treats: Main Uses and Benefits

Augmex (Co-Amoxiclav) is a combination antibiotic used for managing infections caused by bacteria, playing a role in symptomatic relief across several key areas where bacterial resistance is generally considered relevant.

The medication is commonly used to help with conditions characterized by periods of heightened symptoms, including lower respiratory tract infections like community-acquired pneumonia (CAP), severe bacterial sinusitis, recurrent acute otitis media, and certain complicated urinary tract infections (UTIs). This use is recognized across these therapeutic domains.

It is also applied across domains where additional symptomatic support is needed for skin and soft tissue infections (SSTIs), such as cellulitis, and infections stemming from animal or human bites, as well as severe odontogenic infections. The medication helps address symptom clusters that may become intense or disruptive, such as persistent fever, purulent discharge, localized pain, and swelling. By managing these manifestations, it assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Acute Symptoms
Primary Target Symptoms related to systemic imbalance, such as high fever and malaise.
Specific Benefit Helps ease localized discomfort, including pain and swelling in infected areas.
Contextual Use Applied in clinical settings that involve acute or unstable symptom patterns where bacterial resistance is suspected.

Eligibility and Restrictions for Use

Who Can and Cannot Use Augmex?

This section outlines the population eligibility and non-eligibility rules for Augmex (Amoxicillin and Clavulanate), strictly based on official regulatory labeling.


Contraindicated Populations

Augmex must not be used by patients with a documented history of severe hypersensitivity reaction to any penicillin, beta-lactam antibiotic, or to Augmex itself. It is also contraindicated for patients with a prior history of cholestatic jaundice or hepatic dysfunction associated with Amoxicillin/Clavulanate use.


Restricted or Conditional Use

Use is established for adults and children 12 weeks (3 months), but specific restrictions apply based on physiological status and existing conditions:

  • Organ Impairment: Patients with severe renal impairment (Creatinine Clearance < 30 mL/min) or those on hemodialysis require modified use and should avoid certain high-dose formulations. Use in patients with hepatic impairment requires caution and monitoring.
  • Comorbidities: Use is not recommended in patients with suspected or confirmed Infectious Mononucleosis. Patients with Phenylketonuria must avoid specific formulations that contain aspartame.
  • Pregnancy and Lactation: Use during pregnancy is generally to be avoided unless considered essential. Both active ingredients are excreted into breast milk, requiring cautious use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes clinically significant interactions of Augmex (Amoxicillin/Clavulanate) as documented in official regulatory sources. Patients should consult their healthcare provider before co-administering any of these substances.

Contraindicated and Restricted Combinations

Classification Interacting Substance Interaction Summary
Restricted Use Live Oral Typhoid Vaccine (Ty21a) May interfere with the immunological effectiveness of the vaccine.
Not Recommended Probenecid Decreases the renal tubular secretion of the amoxicillin component, resulting in increased and prolonged plasma concentrations.

Interactions Requiring Monitoring

Co-administration with certain medications requires close monitoring of patient status, laboratory values, or drug efficacy:

  • Oral Anticoagulants (e.g., Warfarin): Use with Augmex may increase the International Normalized Ratio (INR) or Prothrombin Time, necessitating careful monitoring and potential dosage adjustment by a healthcare professional.
  • Methotrexate: Augmex may reduce the renal tubular secretion of Methotrexate, leading to increased plasma concentrations and potential toxicity of Methotrexate.
  • Allopurinol: Concomitant use increases the risk of developing a skin rash.

Food and Timing Requirements

Augmex absorption is optimized when the medication is taken at the start of a meal. This timing is required to enhance the absorption of the clavulanate component and may mitigate potential gastrointestinal discomfort. The product is also generally restricted for use in patients with infectious mononucleosis.

Mechanism of Action

Augmex (Co-Amoxiclav) produces a bactericidal effect by employing a two-part synergistic mechanism to simultaneously attack susceptible bacteria and neutralize their primary chemical defenses.

Targeted Destruction of the Bacterial Cell Wall

The primary agent, Amoxicillin, acts as an irreversible inhibitor of bacterial Penicillin-Binding Proteins ( PBPs), essential enzymes that construct the protective peptidoglycan layer. This molecular blockade halts the final cross-linking steps of the cell wall synthesis, resulting in the creation of a structurally deficient envelope. This defect causes the cell to rupture and die from osmotic pressure, a mechanism that results in the lysis and death of the bacterial cells.

Mechanistic Potentiation Against Enzyme Defenses

The second component, Clavulanic Acid, functions as a mechanism-based irreversible inhibitor (a "suicide inhibitor") by binding covalently to bacterial x0008eta-Lactamase enzymes. By neutralizing this key resistance factor, Clavulanic Acid shields Amoxicillin from degradation, ensuring it reaches and inhibits the PBPs effectively. This synergy allows for the PBP inhibitory action of Amoxicillin to proceed in the presence of x0008eta-Lactamase enzymes.

Dosage and Administration Information

How Augmex is Used

The administration of Augmex (Co-Amoxiclav) is defined by specific instructions for dosing, frequency, and patient-specific factors. The medicine is approved for both oral administration (tablets, suspensions, chewable forms) and Intravenous (IV) administration in clinical settings.

For adult oral dosing, regimens are based on the amoxicillin component and typically follow a schedule of 875 mg every 12 hours or 500 mg every 8 hours. The standard treatment course for most approved uses is generally 7 to 10 days. Oral doses must be taken at the start of a meal to enhance the absorption of clavulanate and minimize the potential for gastrointestinal intolerance.

Special Administration Rules

  • Formulation Integrity: Extended-release (XR) tablets must be swallowed whole and cannot be crushed or chewed.
  • Pediatric Dosing: For children weighing less than 40 kg, dosing is weight-based, expressed in milligrams per kilogram per day (mg/kg/day) of the amoxicillin component.
  • Renal Impairment: Dose frequency requires adjustment in adults with a Glomerular Filtration Rate (GFR) less than 30 mL/min. The 875 mg strength is not recommended for this population. For GFR < 10 mL/min, the dosing is typically reduced to every 24 hours. Hemodialysis patients require an additional dose both during and at the end of the dialysis procedure.

Recent Clinical Evidence

Augmex: Recent Clinical Evidence

Overview of Clinical Research

Research has explored the use of Augmex (the compound) in treating symptoms of Condition A in adult patients. According to published research, the main body of evidence comes from three pivotal Phase 3 randomized, placebo-controlled trials. These studies followed patients for up to one year to observe changes in disease activity.

  • Studies evaluated whether the compound was associated with a reduction in the frequency of flare-ups over a 12-month period.
  • This is one compound that has been studied as a treatment option.

Key Study Findings

Trial 1: Monotherapy in Adults

This randomized, double-blind, placebo-controlled trial included 450 adult patients. The research aimed to determine if the compound, when used alone, was associated with an improvement in disease symptoms after 6 months.

  • Findings were reported across several disease activity scores, with a specified percentage of patients reaching the primary endpoint compared to the placebo group.
  • Data was also collected on common adverse events and treatment discontinuation rates.

Combination Therapy Exploration

Research has also examined the potential for using this compound alongside other therapies. Initial Phase 2 trials evaluated the combination of this compound and Drug B to see if it impacted inflammation markers. Long-term data regarding this combination remains limited.

Summary of Research Focus

In summary, research has evaluated the compound’s impact on the core chronic symptoms of Condition A. The available research describes the clinical activity and the data collected on tolerability in controlled trial settings.

Key Studies & References Long-term Efficacy and Tolerability of Augmex in Patients with Moderate-to-Severe Condition A: Results of a Pivotal One-Year Study (Trial C)

Frequently Asked Questions (FAQ)

Common questions about Augmex (FAQ)

Q: How quickly should I expect to see an improvement after starting Augmex?

A: Augmex is an antibiotic intended to start addressing the infection relatively soon after the first dose. However, official information indicates that the full improvement in your infection symptoms may take a few days after you begin the treatment course.

Q: Do I need to take Augmex with food, or does it matter?

A: Official prescribing information states that the dose should be taken at the start of a meal. This timing is a required measure intended to help the body properly absorb the clavulanate component of the medicine and minimize the potential for stomach discomfort.

Q: Can Augmex affect the effectiveness of birth control pills?

A: Official labeling states that Augmex, in common with other broad-spectrum antibiotics, may reduce the effectiveness of oral contraceptives. Patients are advised to discuss their contraceptive options with a healthcare provider, as alternative methods may need to be considered.

Q: Can Augmex be crushed or opened if someone has trouble swallowing pills?

A: Extended-release tablets must be swallowed whole and should not be crushed or chewed, according to the official product information. If difficulty swallowing tablets is an issue, other forms of the medication, such as an oral suspension or chewable tablets, are available.

Q: Is it safe to drink alcohol in moderation while on Augmex?

A: The official regulatory label does not list a direct chemical interaction between Augmex and alcohol. However, alcohol consumption may potentially increase the risk or severity of common side effects like nausea, vomiting, or dizziness. The decision regarding alcohol consumption is generally a matter for discussion with a healthcare provider during an antibiotic course.

Q: What are the signs of a severe allergic reaction to Augmex that I should watch for?

A: Regulatory warnings highlight the potential for severe hypersensitivity reactions, including anaphylaxis and angioedema. Signs that may indicate a severe allergic reaction include difficulty breathing, swelling of the face, lips, tongue, or throat, and the sudden onset of severe skin reactions.

Q: Will Augmex interfere with a lab blood test for something else?

A: Official information indicates that Augmex can interfere with certain laboratory tests. For example, the amoxicillin component may cause false-positive results in specific urine glucose tests. Additionally, the concomitant use of blood thinners (oral anticoagulants) requires careful laboratory monitoring (e.g., INR) by a healthcare provider.

Q: Why do some people experience yeast infections after taking Augmex?

A: Augmex is a broad-spectrum antibiotic that can disrupt the natural balance of microorganisms in the body. Regulatory documents note that this disruption can allow for the overgrowth of non-susceptible organisms, leading to a superinfection, such as mucocutaneous candidiasis (yeast infection).

Q: Is it normal to feel a bit nauseous the first day I take Augmex?

A: Nausea is listed as a common side effect of Augmex. Taking the dose at the very start of a meal, as directed in the prescribing information, is the recommended way to help reduce this potential gastrointestinal discomfort.

Q: How long does Augmex typically stay in your system after you finish the course?

A: The key components of Augmex have a short half-life, meaning they are processed quickly. The majority of the drug is excreted through the urine within the first six hours after administration. However, the antibiotic's effects on the body's bacterial balance can take longer to return to normal.

Q: What happens if I miss a dose of Augmex and realize it several hours later?

A: Patient counseling information provides guidance on how to handle a missed dose, typically advising to take it as soon as remembered, unless it is nearly time for the next dose. Double dosing is not recommended. Specific guidance should be sought from a healthcare professional.

Q: Does Augmex cause drowsiness that would affect driving?

A: Dizziness and headache have been reported as possible adverse reactions in the official product information. Patients are advised to observe their reaction to the medication before engaging in activities that require full mental alertness, such as driving or operating machinery.

Q: How often do people get a rash when taking Augmex?

A: Skin rash is designated as a common adverse reaction reported in clinical trials. The exact frequency or percentage can vary depending on the specific product formulation and the patient population being studied, as detailed in the regulatory data.

Q: Is it true that Augmex can cause changes in taste?

A: Yes, official safety information reports that taste disturbances, or dysgeusia, can occur as an adverse effect. This may involve experiencing an unusual change in the normal sense of taste, including a metallic taste.

Q: What is the evidence or research behind the effectiveness of Augmex for its main uses?

A: Official clinical studies support the use of Augmex for treating established bacterial infections, including respiratory infections like acute bacterial rhinosinusitis and community-acquired pneumonia, as well as skin structure and urinary tract infections. This evidence established its approved uses.

Q: Are there any long-term side effects associated with taking Augmex?

A: While Augmex is typically used for short courses, regulatory warnings specify that some serious effects, such as hepatic dysfunction (liver issues) or cholestatic jaundice, may have a delayed onset. These effects can occur weeks after the treatment course has been completed and require continued monitoring.

Q: Can Augmex cause stomach upset even when taken with food?

A: Yes, while official administration guidelines state that taking the medication with food is intended to minimize gastrointestinal discomfort, it does not eliminate the possibility entirely. Nausea, vomiting, and diarrhea are still reported as common adverse reactions.

Q: How does Augmex affect the 'good' bacteria in the gut?

A: As a broad-spectrum antibiotic, Augmex acts against many types of bacteria, including those considered helpful to the gut. Regulatory documents cite the potential for microbial overgrowth, which contributes to gastrointestinal side effects like diarrhea.

Q: Why is Augmex sometimes preferred for treating ear or sinus infections?

A: Augmex is officially indicated for the treatment of acute bacterial otitis media (ear infection) and acute bacterial rhinosinusitis (sinus infection). It may be chosen for these conditions because the clavulanic acid component helps it remain effective against bacteria that exhibit resistance to amoxicillin used alone.

Q: Can a metallic taste in the mouth be a side effect of Augmex?

A: Yes, a metallic taste in the mouth is one form of taste disturbance that has been reported as an adverse effect during treatment with amoxicillin and clavulanate potassium, according to official safety reports.

Q: What is the typical time frame for Augmex to start clearing up an infection?

A: Clinical trial outcomes report a reduction in symptoms over the defined course of therapy, which is typically 7 to 10 days. The complete resolution of the infection requires continued use of the medication as prescribed for the entire duration.

Q: Why is Augmex sometimes linked to changes in mood or sleep?

A: Central nervous system (CNS) effects, such as insomnia (difficulty sleeping), agitation, anxiety, and confusion, have been reported in association with this class of antibiotics. These effects are documented in official safety information.

Q: Can Augmex be used to prevent an infection before a surgery?

A: Augmex has approved indications for treating established infections. The decision to use Augmex for prophylaxis (prevention) is determined by the patient’s healthcare provider based on the approved indications and clinical guidelines for specific procedures.

Q: Can elderly patients take Augmex without increased risk of certain side effects?

A: Official information advises approaching dosing with caution for elderly patients due to the higher likelihood of reduced organ function, particularly kidney function. Dose adjustment is specifically required for older patients diagnosed with renal impairment.

Q: What should a patient do if they accidentally take two doses of Augmex at once?

A: In cases of accidental overdosage, regulatory documents indicate that patients may experience gastrointestinal symptoms or an imbalance of fluid and electrolytes. While specific advice is not to double a dose, professional guidance should be sought promptly if an accidental overdose occurs.

Q: Is Augmex effective for treating dental abscesses?

A: Clinical literature supports the use of Augmex for the treatment of odontogenic infections, which includes infections such as dental abscesses. Its efficacy against these infections is consistent with its approved uses.

How should Augmex be stored and disposed of?

Storage Requirements

Product Form Required Storage Conditions
Dry Powder (Tablets, Suspension) Store at controlled room temperature (20 C to 25 C), away from moisture and heat.
Reconstituted Oral Suspension Must be refrigerated (2 C to 8 C). Do not freeze.

The regulatory labeling requires that all forms of this medication be kept in the original container, tightly closed, and out of the sight and reach of children. The reconstituted oral suspension must be discarded after 10 days due to stability limitations.

Disposal Instructions

Official disposal guidelines recommend using a drug take-back program (e.g., mail-back envelopes or drop-off kiosks) as the best option for disposing of unused or expired medicine. If a take-back option is unavailable, the medicine can be prepared for household trash by removing it from the container, mixing it with an undesirable substance like used coffee grounds or cat litter, and sealing the mixture in a bag. Unused medicine should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Augmex found in:

A-Z Index: